Moretime Legal supports Immunovia to conclude a cancer test collaboration agreement with OHSU

Moretime Legal has been advising Immunovia in connection with a collaboration agreement on early detection test for pancreactic cancer with the Knight Cancer Institute at Oregon Health & Science University.

The Lund-based cancer diagnosis company Immunovia AB and the Knight Cancer Institute at Oregon Health & Science University (OHSU) has formed a collaboration to confirm, validate and commercialize a blood test for the early diagnosis of pancreatic cancer. The test called IMMray™ PanCan-d analyses a patient’s immune system for early signs of disease. The collaboration will also enable researchers to explore biomarkers for a number of other cancer types. Immunovia is planning an IPO during Q4 2105.

Moretime Legal provided contractual support to Immunovia through a support team consisting of Leif Gallo and Ulf Lindén.

For more information:
Ulf Lindén, General Manager at Moretime Legal
Phone: +46-76-1111730
Email: ulf.linden@moretime.se